Clinical Cancer Research: 1 (3)

The emerging role of paclitaxel in breast cancer therapy.

A D Seidman

Clin Cancer Res March 1 1995 1 (3) 247-256;
AIDS-related Kaposi's sarcoma is a clonal neoplasm.

C S Rabkin, G Bedi, E Musaba, R Sunkutu, N Mwansa, D Sidransky and R J Biggar

Clin Cancer Res March 1 1995 1 (3) 257-260;
Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.

H Tsuda, T Fukutomi and S Hirohashi

Clin Cancer Res March 1 1995 1 (3) 261-267;
A phase I and pharmacokinetic study of a new camptothecin derivative, 9-aminocamptothecin.

E Rubin, V Wood, A Bharti, D Trites, C Lynch, S Hurwitz, S Bartel, S Levy, A Rosowsky and D Toppmeyer

Clin Cancer Res March 1 1995 1 (3) 269-276;
Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.

R de Bree, J C Roos, J J Quak, W den Hollander, A J Wilhelm, A van Lingen, G B Snow and G A Dongen

Clin Cancer Res March 1 1995 1 (3) 277-286;
Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.

P E Goss, R M Clark, U Ambus, H A Weizel, N A Wadden, M Crump, D Walde, L M Tye, R De Coster and J Bruynseels

Clin Cancer Res March 1 1995 1 (3) 287-294;
Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.

S D Gore, L J Weng, R J Jones, K Cowan, M Zilcha, S Piantadosi and P J Burke

Clin Cancer Res March 1 1995 1 (3) 295-303;
Clinical applications of the histoculture drug response assay.

T Furukawa, T Kubota and R M Hoffman

Clin Cancer Res March 1 1995 1 (3) 305-311;
The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.

H O Smith, P S Anderson, D Y Kuo, G L Goldberg, C L DeVictoria, C A Boocock, J G Jones, C D Runowicz, E R Stanley and J W Pollard

Clin Cancer Res March 1 1995 1 (3) 313-325;
Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients.

R Y Lin, P A Argenta, K M Sullivan and N S Adzick

Clin Cancer Res March 1 1995 1 (3) 327-331;
Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.

S A Cannistra, B DeFranzo, J Niloff and C Ottensmeir

Clin Cancer Res March 1 1995 1 (3) 333-342;
Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.

M S Kurian, R S de la Cuesta, G L Waneck, D T MacLaughlin, T F Manganaro and P K Donahoe

Clin Cancer Res March 1 1995 1 (3) 343-349;
Effect of sublethal liver injury on doxorubicin metabolism.

D A August, S Halter and D E Brenner

Clin Cancer Res March 1 1995 1 (3) 351-358;
Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.

J Vachtenheim, I Horáková, H Novotná, P Opáalka and H Roubková

Clin Cancer Res March 1 1995 1 (3) 359-365;

Main menu

User menu

Search

Table of Contents

Articles

Info for

About Clinical Cancer Research